These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 2990710)
1. Combination chemotherapy followed by radiation therapy in patients with regional stage III unresectable non-small cell lung cancer. Fram R; Skarin A; Balikian J; Amato D; Leslie N; Malcolm A; Frei E Cancer Treat Rep; 1985 Jun; 69(6):587-90. PubMed ID: 2990710 [TBL] [Abstract][Full Text] [Related]
2. Etoposide plus cisplatin followed by thoracic radiation for stage IIIB non-small cell lung cancer: MAOP study 2188. Lokich J; Auerbach M; Essig L; Fryer J; Fryer D J Infus Chemother; 1995; 5(2):70-2. PubMed ID: 8521238 [TBL] [Abstract][Full Text] [Related]
3. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group. Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106 [TBL] [Abstract][Full Text] [Related]
4. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial. Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596 [TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach. Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M; J BUON; 2006; 11(1):31-7. PubMed ID: 17318949 [TBL] [Abstract][Full Text] [Related]
6. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases]. Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913 [TBL] [Abstract][Full Text] [Related]
7. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer. Ajlouni M; Chapman R; Kim JH Cancer J Sci Am; 1996; 2(6):314-20. PubMed ID: 9166551 [TBL] [Abstract][Full Text] [Related]
8. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response. Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406 [TBL] [Abstract][Full Text] [Related]
9. Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer. Lindgren D; Cadman E; Erichson R; Grann V; Sachs K Cancer Treat Rep; 1984 Sep; 68(9):1159-61. PubMed ID: 6090015 [TBL] [Abstract][Full Text] [Related]
10. [Whole-brain radiotherapy combined with COAPC regimen in patients with non-small cell lung cancer]. Chen LK; Xu GC; Liu GZ; Liang Y; Liu JL; Zhou XM Ai Zheng; 2003 Apr; 22(4):407-10. PubMed ID: 12704000 [TBL] [Abstract][Full Text] [Related]
11. The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer. Ferguson MK; Little AG; Golomb HM; Hoffman PC; DeMeester TR; Beveridge R; Skinner DB J Thorac Cardiovasc Surg; 1986 Mar; 91(3):344-9. PubMed ID: 3005776 [TBL] [Abstract][Full Text] [Related]
12. Pilot study of induction therapy with cyclophosphamide, doxorubicin, and cisplatin (CAP) and chest irradiation prior to thoracotomy in initially inoperable stage III M0 non-small cell lung cancer. Eagan RT; Ruud C; Lee RE; Pairolero PC; Gail MH Cancer Treat Rep; 1987 Oct; 71(10):895-900. PubMed ID: 2820570 [TBL] [Abstract][Full Text] [Related]
13. [Bronchial arterial infusion chemotherapy with or without radiotherapy for advanced lung cancer]. Huang DP Zhonghua Zhong Liu Za Zhi; 1990 May; 12(3):216-8. PubMed ID: 2249598 [TBL] [Abstract][Full Text] [Related]
14. [Combination chemotherapy and radiation therapy for small cell carcinoma of the lung]. Hara N; Ichinose Y; Motohiro A; Noge S; Miyake J; Ohta M; Hata K Gan To Kagaku Ryoho; 1986 Jan; 13(1):80-5. PubMed ID: 3002286 [TBL] [Abstract][Full Text] [Related]
15. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group. Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975 [TBL] [Abstract][Full Text] [Related]
16. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach. Newman SB; DeMeester TR; Golomb HM; Hoffman PC; Little AG; Raghavan V J Thorac Cardiovasc Surg; 1983 Aug; 86(2):180-5. PubMed ID: 6308356 [TBL] [Abstract][Full Text] [Related]
17. [Means of improving the chemoradiotherapy of small cell cancer of the lung]. Monakhov BV; Borisevich NV; Akyshbaev AA Vopr Onkol; 1988; 34(6):718-21. PubMed ID: 2839938 [TBL] [Abstract][Full Text] [Related]
18. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study. Ettinger DS; Berkey BA; Abrams RA; Fontanesi J; Machtay M; Duncan PJ; Curran WJ; Movsas B; Byhardt RW; J Clin Oncol; 2005 Aug; 23(22):4991-8. PubMed ID: 15939930 [TBL] [Abstract][Full Text] [Related]
19. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer. Kamath SS; McCarley DL; Zlotecki RA Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169 [TBL] [Abstract][Full Text] [Related]
20. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study. Rusu P; Ciuleanu TE; Cernea D; Pelau D; Gaal V; Cebotaru C; Guttman T; Todor N; Ghilezan N J BUON; 2007; 12(1):33-9. PubMed ID: 17436399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]